Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Marcellin, Patrick; Hoon Ahn, Sang; Ma, Xiaoli; Alexandru Căruntu, Florin; Young Tak, Won; Elkashab, Magdy; Chuang, Wan‐Long; Gee Lim, Seng; Tabak, Fehmı; Mehta, Rajiv; Petersen, Joerg; R. Foster, Graham; Lou, Lillian; B. Martins, Eduardo; Dinh, Phillip; Lin, Lanjia; C. Corsa, Amoreena; Charuworn, Prista; Mani Subramanian, G.; Reiser, Hans; Reesink, H.W.; Fung, Scott; I. Strasser, Simone; N. Trinh, Huy; Buti, Marı́a; Battista Gaeta, Giovanni; J. Hui, Aric; Papatheodoridis, George; Flisiak, Robert; Lik‐Yuen Chan, Henry

doi:10.1053/j.gastro.2015.09.043

Public

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

Published in Gastroenterology • Oct 19, 2015

Authors:

Patrick Marcellin

Sang Hoon Ahn

Xiaoli Ma

Abstract

BACKGROUND & AIMS: Patients chronically infected with the hepatitis B virus rarely achieve loss of serum hepatitis B surface antigen (HBsAg) with the standard of care. We evaluated HBsAg loss in patients receiving the combination of tenofovir disoproxil fumarate (TDF) and peginterferon α-2a (peginte...

Subject

HBsAg

Medicine

Discontinuation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!